Last 12 months
Inside the activity.
12 purchase rows · 16 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 8 | 2 |
| Dec 2025 | 4 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 4 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 17, 2022 Filed May 19, 2022 23:38 UTC |
EASTHAM KARINDirector
|
GrantCommon Stock | 10,770 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-030771 · doc4.xml · nonDerivative · entry 1 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,506 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 100% of the shares subject to the RSU shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders occurring after the grant date, subject to the reporting person's Continuous Service (as defined in the Company's 2019 Equity Incentive Plan) through the vesting date. In the event of a change in control (as defined in the Company's 2019 Equity Incentive Plan), the shares underlying the RSU shall vest immediately prior to the effectiveness of such change in control. Read SEC document |
| May 17, 2022 Filed May 19, 2022 19:01 UTC |
LUDLUM KENDirector
|
GrantStock Option (right to buy) · Derivative | 15,035 | $0.00 Strike: $4.81 | $0.00 |
DisclosureSEC source: 0001209191-22-030753 · doc4.xml · derivative · entry 3 LUDLUM KEN · CIK 0001255825 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,035 Underlying: Common Stock · 15,035 shares Expires 2032-05-17 F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders occurring after the grant date, subject to the reporting person's Continuous Service (as defined in the Company's 2019 Equity Incentive Plan) through the vesting date. In the event of a change in control (as defined in the Company's 2019 Equity Incentive Plan), the shares underlying the option shall vest and become immediately exercisable prior to the effectiveness of such change in control. Read SEC document |
| May 17, 2022 Filed May 19, 2022 19:01 UTC |
LUDLUM KENDirector
|
GrantCommon Stock | 10,770 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-030753 · doc4.xml · nonDerivative · entry 1 LUDLUM KEN · CIK 0001255825 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,506 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 100% of the shares subject to the RSU shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders occurring after the grant date, subject to the reporting person's Continuous Service (as defined in the Company's 2019 Equity Incentive Plan) through the vesting date. In the event of a change in control (as defined in the Company's 2019 Equity Incentive Plan), the shares underlying the RSU shall vest immediately prior to the effectiveness of such change in control. Read SEC document |
| May 17, 2022 Filed May 19, 2022 19:11 UTC |
Colowick AlanDirector
|
GrantStock Option (right to buy) · Derivative | 15,035 | $0.00 Strike: $4.81 | $0.00 |
DisclosureSEC source: 0001209191-22-030756 · doc4.xml · derivative · entry 2 Colowick Alan · CIK 0001316163 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,035 Underlying: Common Stock · 15,035 shares Expires 2032-05-17 F2 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders occurring after the grant date, subject to the reporting person's Continuous Service (as defined in the Company's 2019 Equity Incentive Plan) through the vesting date. In the event of a change in control (as defined in the Company's 2019 Equity Incentive Plan), the shares underlying the option shall vest and become immediately exercisable prior to the effectiveness of such change in control. Read SEC document |
| May 17, 2022 Filed May 19, 2022 19:11 UTC |
Colowick AlanDirector
|
GrantCommon Stock | 10,770 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-030756 · doc4.xml · nonDerivative · entry 1 Colowick Alan · CIK 0001316163 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,506 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 100% of the shares subject to the RSU shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders occurring after the grant date, subject to the reporting person's Continuous Service (as defined in the Company's 2019 Equity Incentive Plan) through the vesting date. In the event of a change in control (as defined in the Company's 2019 Equity Incentive Plan), the shares underlying the RSU shall vest immediately prior to the effectiveness of such change in control. Read SEC document |
| May 17, 2022 Filed May 19, 2022 23:50 UTC |
Bloom Olivia KyusukDirector
|
GrantStock Option (right to buy) · Derivative | 15,035 | $0.00 Strike: $4.81 | $0.00 |
DisclosureSEC source: 0001209191-22-030776 · doc4.xml · derivative · entry 2 Bloom Olivia Kyusuk · CIK 0001501545 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,035 Underlying: Common Stock · 15,035 shares Expires 2032-05-17 F2 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders occurring after the grant date, subject to the reporting person's Continuous Service (as defined in the Company's 2019 Equity Incentive Plan) through the vesting date. In the event of a change in control (as defined in the Company's 2019 Equity Incentive Plan), the shares underlying the option shall vest and become immediately exercisable prior to the effectiveness of such change in control. Read SEC document |
| May 17, 2022 Filed May 19, 2022 23:50 UTC |
Bloom Olivia KyusukDirector
|
GrantCommon Stock | 10,770 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-030776 · doc4.xml · nonDerivative · entry 1 Bloom Olivia Kyusuk · CIK 0001501545 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,015 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 100% of the shares subject to the RSU shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders occurring after the grant date, subject to the reporting person's Continuous Service (as defined in the Company's 2019 Equity Incentive Plan) through the vesting date. In the event of a change in control (as defined in the Company's 2019 Equity Incentive Plan), the shares underlying the RSU shall vest immediately prior to the effectiveness of such change in control. Read SEC document |
| May 16, 2022 Filed May 18, 2022 18:16 UTC |
West John StephenDirector · President and CEO
|
SaleCommon Stock | 2,408 | $4.86 | $11,702.88 |
DisclosureSEC source: 0001209191-22-030220 · doc4.xml · nonDerivative · entry 1 West John Stephen · CIK 0001779811 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 382,444 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| May 16, 2022 Filed May 18, 2022 22:17 UTC |
Tachibana AaronChief Financial Officer
|
SaleCommon Stock | 1,286 | $4.86 | $6,249.96 |
DisclosureSEC source: 0001209191-22-030222 · doc4.xml · nonDerivative · entry 1 Tachibana Aaron · CIK 0001401786 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,388 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| May 16, 2022 Filed May 18, 2022 22:14 UTC |
Chen RichardChief Medical Officer
|
SaleCommon Stock | 1,286 | $4.86 | $6,249.96 |
DisclosureSEC source: 0001209191-22-030218 · doc4.xml · nonDerivative · entry 2 Chen Richard · CIK 0001779787 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,830 F2 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. F3 · balance_after: This reflects a reduction of 538 shares due to a scrivener's error on the reporting person's prior filing and does not indicate a purchase and/or sale of such shares. Read SEC document |
| May 16, 2022 Filed May 18, 2022 22:15 UTC |
Moore Stephen MichaelGeneral Counsel
|
SaleCommon Stock | 664 | $4.86 | $3,227.04 |
DisclosureSEC source: 0001209191-22-030219 · doc4.xml · nonDerivative · entry 1 Moore Stephen Michael · CIK 0001915342 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,717 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| May 02, 2022 Filed May 4, 2022 21:38 UTC |
Moore Stephen MichaelGeneral Counsel
|
SaleCommon Stock | 5,733 | $5.53 | $31,703.49 |
DisclosureSEC source: 0001209191-22-027190 · doc4.xml · nonDerivative · entry 1 Moore Stephen Michael · CIK 0001915342 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,381 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| April 29, 2022 Filed May 18, 2022 22:14 UTC |
Chen RichardChief Medical Officer
|
GrantCommon Stock | 1,558 | $4.76 | $7,416.08 |
DisclosureSEC source: 0001209191-22-030218 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,116 F1 · shares: Includes 1,558 shares acquired under the Issuer's Employee Stock Purchase Plan dated April 29, 2022. Read SEC document |
| April 20, 2022 Filed Apr 22, 2022 17:25 UTC |
West John StephenDirector · President and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 45,061 | $0.00 Strike: $1.84 | $0.00 |
DisclosureSEC source: 0001209191-22-025418 · doc4.xml · derivative · entry 2 West John Stephen · CIK 0001779811 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 45,061 shares Expires 2024-03-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| April 20, 2022 Filed Apr 22, 2022 17:25 UTC |
West John StephenDirector · President and CEO
|
Exercise / conversionCommon Stock | 45,061 | $1.84 | $82,912.24 |
DisclosureSEC source: 0001209191-22-025418 · doc4.xml · nonDerivative · entry 1 West John Stephen · CIK 0001779811 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 384,852 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| April 13, 2022 Filed Apr 15, 2022 18:24 UTC |
West John StephenDirector · President and CEO
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 64,430 | $0.00 Strike: $1.84 | $0.00 |
DisclosureSEC source: 0001209191-22-024534 · doc4.xml · derivative · entry 3 West John Stephen · CIK 0001779811 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 64,430 shares Expires 2023-12-11 F4 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| April 13, 2022 Filed Apr 15, 2022 18:24 UTC |
West John StephenDirector · President and CEO
|
SaleCommon Stock | 64,430 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-024534 · doc4.xml · nonDerivative · entry 2 West John Stephen · CIK 0001779811 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 339,791 F3 · price: The weighted average sale price for the transaction reported was $7.40, and the range of prices were between $7.31 and $7.57. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| April 13, 2022 Filed Apr 15, 2022 18:24 UTC |
West John StephenDirector · President and CEO
|
Exercise / conversionCommon Stock | 64,430 | $1.84 | $118,551.20 |
DisclosureSEC source: 0001209191-22-024534 · doc4.xml · nonDerivative · entry 1 West John Stephen · CIK 0001779811 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 404,221 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The exercise and sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · balance_after: This reflects a reduction of 13 shares due to a scrivener's error on the reporting person's prior filings and does not indicate a purchase and/or sale of such shares. Read SEC document |
| March 17, 2022 Filed Mar 21, 2022 20:44 UTC |
West John StephenDirector · President and CEO
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 54,347 | $0.00 Strike: $1.84 | $0.00 |
DisclosureSEC source: 0001209191-22-020420 · doc4.xml · derivative · entry 2 West John Stephen · CIK 0001779811 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 54,347 shares Expires 2023-11-13 F2 · derivative.exercise_date: The Shares subject to the option are fully vested and exercisable. Read SEC document |
| March 17, 2022 Filed Mar 21, 2022 20:44 UTC |
West John StephenDirector · President and CEO
|
GrantCommon Stock | 54,347 | $1.84 | $99,998.48 |
DisclosureSEC source: 0001209191-22-020420 · doc4.xml · nonDerivative · entry 1 West John Stephen · CIK 0001779811 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 339,804 F1 · shares: The exercised reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| March 17, 2022 Filed Mar 22, 2022 00:42 UTC |
Tachibana AaronChief Financial Officer
|
Disposition to issuerCommon Stock | 3,767 | $7.98 | $30,060.66 |
DisclosureSEC source: 0001209191-22-020419 · doc4.xml · nonDerivative · entry 1 Tachibana Aaron · CIK 0001401786 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 247,674 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| March 17, 2022 Filed Mar 22, 2022 00:41 UTC |
Chen RichardChief Medical Officer
|
Disposition to issuerCommon Stock | 1,776 | $7.98 | $14,172.48 |
DisclosureSEC source: 0001209191-22-020418 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,558 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| March 15, 2022 Filed Mar 16, 2022 20:40 UTC |
West John StephenDirector · President and CEO
|
Disposition to issuerCommon Stock (Right to Buy) · Derivative | 68,162 | $0.00 Strike: $1.84 | $0.00 |
DisclosureSEC source: 0001209191-22-019360 · doc4.xml · derivative · entry 6 West John Stephen · CIK 0001779811 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,346 Underlying: Common Stock · 68,162 shares Expires 2023-11-13 F4 · derivative.exercise_date: The Shares subject to the option are fully vested and exercisable. Read SEC document |
| March 15, 2022 Filed Mar 16, 2022 20:40 UTC |
West John StephenDirector · President and CEO
|
Disposition to issuerCommon Stock | 68,162 | $7.47 | $509,170.14 |
DisclosureSEC source: 0001209191-22-019360 · doc4.xml · nonDerivative · entry 4 West John Stephen · CIK 0001779811 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 285,457 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The weighted average sale price for the transaction reported was $7.47, and the range of prices were between $7.35 and $7.655. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| March 15, 2022 Filed Mar 16, 2022 20:40 UTC |
West John StephenDirector · President and CEO
|
GrantCommon Stock | 68,162 | $1.84 | $125,418.08 |
DisclosureSEC source: 0001209191-22-019360 · doc4.xml · nonDerivative · entry 3 West John Stephen · CIK 0001779811 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 353,619 Read SEC document |
| March 14, 2022 Filed Mar 16, 2022 20:40 UTC |
West John StephenDirector · President and CEO
|
Disposition to issuerCommon Stock (Right to Buy) · Derivative | 21,206 | $0.00 Strike: $1.84 | $0.00 |
DisclosureSEC source: 0001209191-22-019360 · doc4.xml · derivative · entry 5 West John Stephen · CIK 0001779811 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,508 Underlying: Common Stock · 21,206 shares Expires 2023-11-13 F4 · derivative.exercise_date: The Shares subject to the option are fully vested and exercisable. Read SEC document |
| March 14, 2022 Filed Mar 16, 2022 20:40 UTC |
West John StephenDirector · President and CEO
|
Disposition to issuerCommon Stock | 21,206 | $8.15 | $172,828.90 |
DisclosureSEC source: 0001209191-22-019360 · doc4.xml · nonDerivative · entry 2 West John Stephen · CIK 0001779811 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 285,457 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The weighted average sale price for the transaction reported was $8.15, and the range of prices were between $7.95 and $8.37. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| March 14, 2022 Filed Mar 16, 2022 20:40 UTC |
West John StephenDirector · President and CEO
|
GrantCommon Stock | 21,206 | $1.84 | $39,019.04 |
DisclosureSEC source: 0001209191-22-019360 · doc4.xml · nonDerivative · entry 1 West John Stephen · CIK 0001779811 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 306,663 Read SEC document |
| March 11, 2022 Filed Mar 14, 2022 17:56 UTC |
West John StephenDirector · President and CEO
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 10,888 | $0.00 Strike: $1.84 | $0.00 |
DisclosureSEC source: 0001209191-22-018603 · doc4.xml · derivative · entry 4 West John Stephen · CIK 0001779811 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,714 Underlying: Common Stock · 10,888 shares Expires 2023-11-13 F4 · derivative.exercise_date: The Shares subject to the option are fully vested and exercisable. Read SEC document |
| March 11, 2022 Filed Mar 14, 2022 17:56 UTC |
West John StephenDirector · President and CEO
|
Disposition to issuerCommon Stock | 10,888 | $8.99 | $97,883.12 |
DisclosureSEC source: 0001209191-22-018603 · doc4.xml · nonDerivative · entry 2 West John Stephen · CIK 0001779811 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 241,672 F2 · price: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The weighted average sale price for the transaction reported was $8.99, and the range of prices were between $9.38 and $8.83. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| March 11, 2022 Filed Mar 16, 2022 20:39 UTC Amendment |
West John StephenDirector · President and CEO
|
Disposition to issuerCommon Stock | 10,888 | $8.99 | $97,883.12 |
DisclosureSEC source: 0001209191-22-019359 · doc4a.xml · nonDerivative · entry 4 West John Stephen · CIK 0001779811 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 285,457 F1 · shares: The exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The weighted average sale price for the transaction reported was $8.99, and the range of prices were between $8.83 and $9.38. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| March 11, 2022 Filed Mar 16, 2022 20:39 UTC Amendment |
West John StephenDirector · President and CEO
|
GrantCommon Stock | 10,888 | $1.84 | $20,033.92 |
DisclosureSEC source: 0001209191-22-019359 · doc4a.xml · nonDerivative · entry 3 West John Stephen · CIK 0001779811 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 296,339 Read SEC document |
| March 10, 2022 Filed Mar 14, 2022 17:56 UTC |
West John StephenDirector · President and CEO
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 32,897 | $0.00 Strike: $1.84 | $0.00 |
DisclosureSEC source: 0001209191-22-018603 · doc4.xml · derivative · entry 3 West John Stephen · CIK 0001779811 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,602 Underlying: Common Stock · 32,897 shares Expires 2023-11-13 F4 · derivative.exercise_date: The Shares subject to the option are fully vested and exercisable. Read SEC document |
| March 10, 2022 Filed Mar 14, 2022 17:56 UTC |
West John StephenDirector · President and CEO
|
Disposition to issuerCommon Stock | 32,897 | $9.38 | $308,573.86 |
DisclosureSEC source: 0001209191-22-018603 · doc4.xml · nonDerivative · entry 1 West John Stephen · CIK 0001779811 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 252,560 F1 · price: The weighted average sale price for the transaction reported was $9.38, and the range of prices were between $9.35 and $9.805. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. F2 · price: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| March 10, 2022 Filed Mar 16, 2022 20:39 UTC Amendment |
West John StephenDirector · President and CEO
|
Disposition to issuerCommon Stock | 32,897 | $9.38 | $308,573.86 |
DisclosureSEC source: 0001209191-22-019359 · doc4a.xml · nonDerivative · entry 2 West John Stephen · CIK 0001779811 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 285,457 F1 · shares: The exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The weighted average sale price for the transaction reported was $9.38, and the range of prices were between $9.35 and $9.805. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| March 10, 2022 Filed Mar 16, 2022 20:39 UTC Amendment |
West John StephenDirector · President and CEO
|
GrantCommon Stock | 32,897 | $1.84 | $60,530.48 |
DisclosureSEC source: 0001209191-22-019359 · doc4a.xml · nonDerivative · entry 1 West John Stephen · CIK 0001779811 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 318,354 Read SEC document |
| March 03, 2022 Filed Mar 4, 2022 20:27 UTC |
Lightspeed Venture Partners Select IV, L.P.Affiliate of 10% Owner
Mhatre RaviAffiliate of 10% Owner
Lightspeed General Partner Select IV, L.P.Affiliate of 10% Owner
Lightspeed Ultimate General Partner Select IV, L.L.C.Affiliate of 10% Owner
Janmohamed ArifAffiliate of 10% Owner
Eggers BarryAffiliate of 10% Owner
Nieh PeterAffiliate of 10% Owner
|
PurchaseCommon Stock | 4,750 | $10.38 | $49,305.00 |
DisclosureSEC source: 0001209191-22-016514 · doc4.xml · nonDerivative · entry 3 Lightspeed Venture Partners Select IV, L.P. · CIK 0001805207 · Affiliate of 10% Owner Mhatre Ravi · CIK 0001366050 · Affiliate of 10% Owner Lightspeed General Partner Select IV, L.P. · CIK 0001813995 · Affiliate of 10% Owner Lightspeed Ultimate General Partner Select IV, L.L.C. · CIK 0001813999 · Affiliate of 10% Owner Janmohamed Arif · CIK 0001813938 · Affiliate of 10% Owner Eggers Barry · CIK 0001366048 · Affiliate of 10% Owner Nieh Peter · CIK 0001366051 · Affiliate of 10% Owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,750 F4 · price: This transaction was executed in multiple trades at prices ranging from $10.22 to $10.50. The price reported above reflects the weighted average price. The reporting persons hereby undertake to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F5 · ownership.direct: Shares are held by Peter Nieh. Read SEC document |
| March 03, 2022 Filed Mar 4, 2022 20:27 UTC |
Lightspeed Venture Partners Select IV, L.P.Affiliate of 10% Owner
Mhatre RaviAffiliate of 10% Owner
Lightspeed General Partner Select IV, L.P.Affiliate of 10% Owner
Lightspeed Ultimate General Partner Select IV, L.L.C.Affiliate of 10% Owner
Janmohamed ArifAffiliate of 10% Owner
Eggers BarryAffiliate of 10% Owner
Nieh PeterAffiliate of 10% Owner
|
PurchaseCommon Stock | 261,011 | $9.83 | $2,565,738.13 |
DisclosureSEC source: 0001209191-22-016514 · doc4.xml · nonDerivative · entry 2 Lightspeed Venture Partners Select IV, L.P. · CIK 0001805207 · Affiliate of 10% Owner Mhatre Ravi · CIK 0001366050 · Affiliate of 10% Owner Lightspeed General Partner Select IV, L.P. · CIK 0001813995 · Affiliate of 10% Owner Lightspeed Ultimate General Partner Select IV, L.L.C. · CIK 0001813999 · Affiliate of 10% Owner Janmohamed Arif · CIK 0001813938 · Affiliate of 10% Owner Eggers Barry · CIK 0001366048 · Affiliate of 10% Owner Nieh Peter · CIK 0001366051 · Affiliate of 10% Owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,084,240 F3 · price: This transaction was executed in multiple trades at prices ranging from $9.54 to $10.19. The price reported above reflects the weighted average price. The reporting persons hereby undertake to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.direct: Shares held by Lightspeed Venture Partners Select IV, L.P. ("Lightspeed Select IV"). Lightspeed General Partner Select IV, L.P. ("LGP Select IV") is the general partner of Lightspeed Select IV. Lightspeed Ultimate General Partner Select IV, L.L.C. ("LUGP Select IV") is the general partner of LGP Select IV. Ravi Mhatre and Arif Janmohamed are the managers of LUGP Select IV and share voting and dispositive power with respect to the shares held by Lightspeed Select IV. LGP Select IV, LUGP Select IV and Messrs. Mhatre and Janmohamed disclaim beneficial ownership of the shares held by Lightspeed Select IV except to the extent of their respective pecuniary interests therein. F2 · ownership.nature: Shares held by Lightspeed Venture Partners Select IV, L.P. ("Lightspeed Select IV"). Lightspeed General Partner Select IV, L.P. ("LGP Select IV") is the general partner of Lightspeed Select IV. Lightspeed Ultimate General Partner Select IV, L.L.C. ("LUGP Select IV") is the general partner of LGP Select IV. Ravi Mhatre and Arif Janmohamed are the managers of LUGP Select IV and share voting and dispositive power with respect to the shares held by Lightspeed Select IV. LGP Select IV, LUGP Select IV and Messrs. Mhatre and Janmohamed disclaim beneficial ownership of the shares held by Lightspeed Select IV except to the extent of their respective pecuniary interests therein. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 20:27 UTC |
Lightspeed Venture Partners Select IV, L.P.Affiliate of 10% Owner
Mhatre RaviAffiliate of 10% Owner
Lightspeed General Partner Select IV, L.P.Affiliate of 10% Owner
Lightspeed Ultimate General Partner Select IV, L.L.C.Affiliate of 10% Owner
Janmohamed ArifAffiliate of 10% Owner
Eggers BarryAffiliate of 10% Owner
Nieh PeterAffiliate of 10% Owner
|
PurchaseCommon Stock | 48,989 | $9.96 | $487,930.44 |
DisclosureSEC source: 0001209191-22-016514 · doc4.xml · nonDerivative · entry 1 Lightspeed Venture Partners Select IV, L.P. · CIK 0001805207 · Affiliate of 10% Owner Mhatre Ravi · CIK 0001366050 · Affiliate of 10% Owner Lightspeed General Partner Select IV, L.P. · CIK 0001813995 · Affiliate of 10% Owner Lightspeed Ultimate General Partner Select IV, L.L.C. · CIK 0001813999 · Affiliate of 10% Owner Janmohamed Arif · CIK 0001813938 · Affiliate of 10% Owner Eggers Barry · CIK 0001366048 · Affiliate of 10% Owner Nieh Peter · CIK 0001366051 · Affiliate of 10% Owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,823,229 F1 · price: This transaction was executed in multiple trades at prices ranging from $9.70 to $10.06. The price reported above reflects the weighted average price. The reporting persons hereby undertake to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.direct: Shares held by Lightspeed Venture Partners Select IV, L.P. ("Lightspeed Select IV"). Lightspeed General Partner Select IV, L.P. ("LGP Select IV") is the general partner of Lightspeed Select IV. Lightspeed Ultimate General Partner Select IV, L.L.C. ("LUGP Select IV") is the general partner of LGP Select IV. Ravi Mhatre and Arif Janmohamed are the managers of LUGP Select IV and share voting and dispositive power with respect to the shares held by Lightspeed Select IV. LGP Select IV, LUGP Select IV and Messrs. Mhatre and Janmohamed disclaim beneficial ownership of the shares held by Lightspeed Select IV except to the extent of their respective pecuniary interests therein. F2 · ownership.nature: Shares held by Lightspeed Venture Partners Select IV, L.P. ("Lightspeed Select IV"). Lightspeed General Partner Select IV, L.P. ("LGP Select IV") is the general partner of Lightspeed Select IV. Lightspeed Ultimate General Partner Select IV, L.L.C. ("LUGP Select IV") is the general partner of LGP Select IV. Ravi Mhatre and Arif Janmohamed are the managers of LUGP Select IV and share voting and dispositive power with respect to the shares held by Lightspeed Select IV. LGP Select IV, LUGP Select IV and Messrs. Mhatre and Janmohamed disclaim beneficial ownership of the shares held by Lightspeed Select IV except to the extent of their respective pecuniary interests therein. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 23:08 UTC |
Tachibana AaronChief Financial Officer
|
SaleCommon Stock | 4,511 | $10.18 | $45,921.98 |
DisclosureSEC source: 0001209191-22-016449 · doc4.xml · nonDerivative · entry 1 Tachibana Aaron · CIK 0001401786 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 251,441 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 23:09 UTC |
Chen RichardChief Medical Officer
|
SaleCommon Stock | 471 | $10.18 | $4,794.78 |
DisclosureSEC source: 0001209191-22-016451 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,334 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 22:55 UTC |
Bloom Olivia KyusukDirector
|
GrantCommon Stock | 10,245 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-014995 · doc4.xml · nonDerivative · entry 1 Bloom Olivia Kyusuk · CIK 0001501545 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,245 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. The RSUs vest in 3 annual installments with the first installment vesting on March 1, 2023. Read SEC document |
| January 28, 2022 Filed Feb 1, 2022 23:04 UTC |
Tachibana AaronChief Financial Officer
|
SaleCommon Stock | 705 | $9.93 | $7,000.65 |
DisclosureSEC source: 0001209191-22-006004 · doc4.xml · nonDerivative · entry 1 Tachibana Aaron · CIK 0001401786 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,952 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| January 28, 2022 Filed Feb 1, 2022 23:05 UTC |
Chen RichardChief Medical Officer
|
SaleCommon Stock | 705 | $9.93 | $7,000.65 |
DisclosureSEC source: 0001209191-22-006005 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,805 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| January 19, 2022 Filed Jan 19, 2022 19:22 UTC |
West John StephenDirector · President and CEO
|
SaleCommon Stock | 64,503 | $11.01 | $710,178.03 |
DisclosureSEC source: 0001209191-22-003860 · doc4.xml · nonDerivative · entry 2 West John Stephen · CIK 0001779811 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 285,457 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 3, 2020. F3 · price: This transaction was executed in multiple trades at prices ranging from $10.65 to $11.57. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 18, 2022 Filed Jan 19, 2022 19:22 UTC |
West John StephenDirector · President and CEO
|
SaleCommon Stock | 35,484 | $11.73 | $416,227.32 |
DisclosureSEC source: 0001209191-22-003860 · doc4.xml · nonDerivative · entry 1 West John Stephen · CIK 0001779811 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 349,960 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 3, 2020. F2 · price: This transaction was executed in multiple trades at prices ranging from $11.66 to $11.88. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 17, 2021 Filed Dec 20, 2021 19:00 UTC |
West John StephenDirector · President and CEO
|
SaleCommon Stock | 2,732 | $12.80 | $34,969.60 |
DisclosureSEC source: 0001209191-21-070651 · doc4.xml · nonDerivative · entry 1 West John Stephen · CIK 0001779811 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 385,444 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| December 17, 2021 Filed Dec 21, 2021 00:59 UTC |
Tachibana AaronChief Financial Officer
|
SaleCommon Stock | 3,437 | $12.80 | $43,993.60 |
DisclosureSEC source: 0001209191-21-070678 · doc4.xml · nonDerivative · entry 1 Tachibana Aaron · CIK 0001401786 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,657 Read SEC document |
| December 17, 2021 Filed Dec 21, 2021 00:10 UTC |
Chen RichardChief Medical Officer
|
SaleCommon Stock | 1,563 | $12.80 | $20,006.40 |
DisclosureSEC source: 0001209191-21-070654 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,510 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| December 16, 2021 Filed Dec 17, 2021 21:17 UTC |
West John StephenDirector · President and CEO
|
SaleCommon Stock | 97,268 | $13.42 | $1,305,336.56 |
DisclosureSEC source: 0001209191-21-070470 · doc4.xml · nonDerivative · entry 1 West John Stephen · CIK 0001779811 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 388,176 F1 · shares: The sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The weighted average sale price for the transaction reported was $13.42, and the range of prices were between $13.11 and $13.91. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.